The Centers for Medicare & Medicaid Services (CMS) recently issued a proposed rule establishing a new mandatory payment model for Medicare Part B drugs. CMS said the two-phase model would test whether the alternative drug payment design will lead to a reduction in Medicare spending, while preserving or enhancing the quality of care for Medicare beneficiaries.
This webinar provides an overview of the proposals including:
Geographic areas selected and trial design of the two-phase model
Part B drug add-on payment changes starting in phase one
Application of value-based purchasing tools starting in phase two
Interactions with other payment policies
Provider, supplier, and beneficiary protections
EXPERT PRESENTER
Marla Kugel, MPH, Principal Research Scientist, Premier Inc.

Previous Presentation

A Pharmacy Discussion

What does the future hold for pharmacy benefit managers (PBMs)?
This webinar discusses:
How to better man...